P78344 (IF4G2_HUMAN) Reviewed, UniProtKB/Swiss-Prot
Last modified
May 1, 2013.
Version 122.
History...
Names·Attributes·General annotation·Ontologies·Interactions·Alt products·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Interactions·Alt products·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: Eukaryotic translation initiation factor 4 gamma 2 Short name=eIF-4-gamma 2 Short name=eIF-4G 2 Short name=eIF4G 2 Alternative name(s): Death-associated protein 5 Short name=DAP-5 p97 | ||||||
| Gene names |
| ||||||
| Organism | Homo sapiens (Human) [Reference proteome] | ||||||
| Taxonomic identifier | 9606 [NCBI] | ||||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo![]() |
Protein attributes
| Sequence length | 907 AA. |
| Sequence status | Complete. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | Appears to play a role in the switch from cap-dependent to IRES-mediated translation during mitosis, apoptosis and viral infection. Cleaved by some caspases and viral proteases. Ref.1 Ref.3 Ref.10 Ref.11 |
| Subunit structure | Interacts with the serine/threonine protein kinases MKNK1 and MKNK2. Binds EIF4A and EIF3. Interacts with MIF4GD. Ref.1 Ref.2 Ref.9 Ref.14 |
| Tissue specificity | Ubiquitously expressed in all adult tissues examined, with high levels in skeletal muscle and heart. Also expressed in fetal brain, lung, liver and kidney. Ref.1 Ref.2 Ref.3 |
| Post-translational modification | Phosphorylation; hyperphosphorylated during mitosis. Ref.10 |
| Miscellaneous | This gene has been shown to be extensively edited in the liver of APOBEC1 transgenic animal model. Its aberrant editing could contribute to the potent oncogenesis induced by overexpression of APOBEC1. The aberrant edited sequence, called NAT1, is likely to be a fundamental translational repressor. |
| Sequence similarities | Belongs to the eukaryotic initiation factor 4G family. Contains 1 MI domain. Contains 1 MIF4G domain. Contains 1 W2 domain. |
| Caution | According to Ref.1, this sequence initiates exclusively at a GTG codon. |
| Sequence caution | The sequence BAB93515.1 differs from that shown. Reason: Erroneous initiation. Translation N-terminally extended. The sequence BAD97268.1 differs from that shown. Reason: Unusual initiator. The initiator methionine is coded by a non-canonical GTG valine codon. The sequence CAA61857.1 differs from that shown. Reason: Unusual initiator. The initiator methionine is coded by a non-canonical GTG valine codon. |
Ontologies
Binary interactions
With | Entry | #Exp. | IntAct | Notes |
|---|---|---|---|---|
| EIF4A1 | P60842 | 2 | EBI-296519,EBI-73449 |
Alternative products
| This entry describes 2 isoforms produced by alternative splicing. [Align] [Select] | ||||||
| Isoform 1 (identifier: P78344-1) This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry. | ||||||
| Isoform 2 (identifier: P78344-2) The sequence of this isoform differs from the canonical sequence as follows: 434-471: Missing. | ||||||
| Note: No experimental confirmation available. |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Molecule processing | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chain | 1 – 907 | 907 | Eukaryotic translation initiation factor 4 gamma 2 | PRO_0000213325 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Regions | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Domain | 78 – 308 | 231 | MIF4G | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Domain | 543 – 666 | 124 | MI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Domain | 720 – 904 | 185 | W2 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Amino acid modifications | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 1 | 1 | N-acetylmethionine Ref.7 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 395 | 1 | Phosphoserine Ref.17 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 508 | 1 | Phosphothreonine Ref.10 Ref.16 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 514 | 1 | Phosphothreonine Ref.15 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 902 | 1 | Phosphoserine Ref.17 Ref.19 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Natural variations | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Alternative sequence | 434 – 471 | 38 | Missing in isoform 2. | VSP_038726 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Natural variant | 236 | 1 | L → M. Corresponds to variant rs34885591 [ dbSNP | Ensembl ]. | VAR_048923 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Experimental info | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Sequence conflict | 169 | 1 | S → P in AAC51166. Ref.2 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Sequence conflict | 233 | 1 | K → Q in AAC51166. Ref.2 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Sequence conflict | 245 | 1 | K → Q in AAC51166. Ref.2 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Sequence conflict | 351 | 1 | F → L in AAC51166. Ref.2 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Sequence conflict | 441 | 1 | N → S in AAH18746. Ref.6 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Sequence conflict | 531 | 1 | A → G in AAC51166. Ref.2 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Sequence conflict | 534 | 1 | S → N in AAH43149. Ref.6 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Sequence conflict | 613 | 1 | A → G in AAC51166. Ref.2 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Sequence conflict | 861 | 1 | I → S in AAC51166. Ref.2 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Sequence conflict | 899 | 1 | E → G in AAC51166. Ref.2 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Secondary structure | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Helix Strand Turn | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 541 – 558 | 18 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 561 – 571 | 11 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 575 – 577 | 3 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 578 – 590 | 13 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 594 – 609 | 16 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 615 – 627 | 13 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 629 – 635 | 7 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 639 – 652 | 14 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 658 – 665 | 8 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 666 – 668 | 3 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Turn | 669 – 672 | 4 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 673 – 684 | 12 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 687 – 697 | 11 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 702 – 704 | 3 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 707 – 709 | 3 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 712 – 722 | 11 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 725 – 727 | 3 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 731 – 743 | 13 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 747 – 757 | 11 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 760 – 764 | 5 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 766 – 784 | 19 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 799 – 820 | 22 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 824 – 840 | 17 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 847 – 857 | 11 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 863 – 871 | 9 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 880 – 895 | 16 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sequences
| ||||||||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "A new translational regulator with homology to eukaryotic translation initiation factor 4G." Imataka H., Olsen H.S., Sonenberg N. EMBO J. 16:817-825(1997) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, TISSUE SPECIFICITY, IDENTIFICATION OF A NON-AUG INITIATOR START CODON, INTERACTION WITH EIF4A AND EIF3. Tissue: Placenta. |
| [2] | "A novel translational repressor mRNA is edited extensively in livers containing tumors caused by the transgene expression of the apoB mRNA-editing enzyme." Yamanaka S., Poksay K.S., Arnold K.S., Innerarity T.L. Genes Dev. 11:321-333(1997) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), TISSUE SPECIFICITY, INTERACTION WITH EIF4A. Tissue: Liver. |
| [3] | "DAP-5, a novel homolog of eukaryotic translation initiation factor 4G isolated as a putative modulator of gamma interferon-induced programmed cell death." Levy-Strumpf N., Deiss L.P., Berissi H., Kimchi A. Mol. Cell. Biol. 17:1615-1625(1997) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, TISSUE SPECIFICITY. Tissue: Kidney. |
| [4] | Totoki Y., Toyoda A., Takeda T., Sakaki Y., Tanaka A., Yokoyama S. Submitted (APR-2005) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1). Tissue: Kidney. |
| [5] | "Human chromosome 11 DNA sequence and analysis including novel gene identification." Taylor T.D., Noguchi H., Totoki Y., Toyoda A., Kuroki Y., Dewar K., Lloyd C., Itoh T., Takeda T., Kim D.-W., She X., Barlow K.F., Bloom T., Bruford E., Chang J.L., Cuomo C.A., Eichler E., FitzGerald M.G. Sakaki Y.Nature 440:497-500(2006) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [6] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2). Tissue: Retinal pigment epithelium, Skin and Testis. |
| [7] | "Exploring proteomes and analyzing protein processing by mass spectrometric identification of sorted N-terminal peptides." Gevaert K., Goethals M., Martens L., Van Damme J., Staes A., Thomas G.R., Vandekerckhove J. Nat. Biotechnol. 21:566-569(2003) [PubMed] [Europe PMC] [Abstract] Cited for: PROTEIN SEQUENCE OF 1-12, ACETYLATION AT MET-1. Tissue: Platelet. |
| [8] | "Identification of immuno-peptidmics that are recognized by tumor-reactive CTL generated from TIL of colon cancer patients." Shichijo S., Itoh K. Submitted (JUN-2001) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 679-907. Tissue: Colon adenocarcinoma. |
| [9] | "Human eukaryotic translation initiation factor 4G (eIF4G) recruits mnk1 to phosphorylate eIF4E." Pyronnet S., Imataka H., Gingras A.-C., Fukunaga R., Hunter T., Sonenberg N. EMBO J. 18:270-279(1999) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH MKNK1. |
| [10] | "Suppression of cap-dependent translation in mitosis." Pyronnet S., Dostie J., Sonenberg N. Genes Dev. 15:2083-2093(2001) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION, PHOSPHORYLATION. |
| [11] | "The caspase-cleaved DAP5 protein supports internal ribosome entry site-mediated translation of death proteins." Henis-Korenblit S., Shani G., Sines T., Marash L., Shohat G., Kimchi A. Proc. Natl. Acad. Sci. U.S.A. 99:5400-5405(2002) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION. |
| [12] | "A probability-based approach for high-throughput protein phosphorylation analysis and site localization." Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P. Nat. Biotechnol. 24:1285-1292(2006) [PubMed] [Europe PMC] [Abstract] Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. Tissue: Cervix carcinoma. |
| [13] | "Phosphoproteome of resting human platelets." Zahedi R.P., Lewandrowski U., Wiesner J., Wortelkamp S., Moebius J., Schuetz C., Walter U., Gambaryan S., Sickmann A. J. Proteome Res. 7:526-534(2008) [PubMed] [Europe PMC] [Abstract] Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. Tissue: Platelet. |
| [14] | "SLIP1, a factor required for activation of histone mRNA translation by the stem-loop binding protein." Cakmakci N.G., Lerner R.S., Wagner E.J., Zheng L., Marzluff W.F. Mol. Cell. Biol. 28:1182-1194(2008) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH MIF4GD. |
| [15] | "A quantitative atlas of mitotic phosphorylation." Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E., Elledge S.J., Gygi S.P. Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-514, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [16] | "Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions." Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K., Rodionov V., Han D.K. Sci. Signal. 2:RA46-RA46(2009) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-508, MASS SPECTROMETRY. Tissue: Leukemic T-cell. |
| [17] | "Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis." Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L., Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M. Sci. Signal. 3:RA3-RA3(2010) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-395 AND SER-902, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [18] | "Initial characterization of the human central proteome." Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J. BMC Syst. Biol. 5:17-17(2011) [PubMed] [Europe PMC] [Abstract] Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. |
| [19] | "System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation." Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B. Sci. Signal. 4:RS3-RS3(2011) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-902, MASS SPECTROMETRY. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EMBL GenBank DDBJ | U73824 mRNA. Translation: AAB49973.1. U76111 mRNA. Translation: AAC51166.1. X89713 mRNA. Translation: CAA61857.1. Sequence problems. AK223548 mRNA. Translation: BAD97268.1. Sequence problems. AC116535 Genomic DNA. No translation available. BC014930 mRNA. Translation: AAH14930.2. BC018746 mRNA. Translation: AAH18746.1. BC018975 mRNA. Translation: AAH18975.1. BC039851 mRNA. Translation: AAH39851.1. BC043149 mRNA. Translation: AAH43149.2. BC111415 mRNA. Translation: AAI11416.1. BC111548 mRNA. Translation: AAI11549.2. AB063323 mRNA. Translation: BAB93515.1. Different initiation. | ||||||||||||||||||
| IPI | IPI00782985. IPI01022651. | ||||||||||||||||||
| RefSeq | NP_001036024.3. NM_001042559.2. NP_001166176.1. NM_001172705.1. NP_001409.3. NM_001418.3. | ||||||||||||||||||
| UniGene | Hs.183684. | ||||||||||||||||||
3D structure databases | |||||||||||||||||||
| PDBe RCSB PDB PDBj |
| ||||||||||||||||||
| ProteinModelPortal | P78344. | ||||||||||||||||||
| ModBase | Search... | ||||||||||||||||||
Protein-protein interaction databases | |||||||||||||||||||
| IntAct | P78344. 7 interactions. | ||||||||||||||||||
| MINT | MINT-1182471. | ||||||||||||||||||
| STRING | 9606.ENSP00000340281. | ||||||||||||||||||
PTM databases | |||||||||||||||||||
| PhosphoSite | P78344. | ||||||||||||||||||
Polymorphism databases | |||||||||||||||||||
| DMDM | 30315906. | ||||||||||||||||||
Proteomic databases | |||||||||||||||||||
| PaxDb | P78344. | ||||||||||||||||||
| PRIDE | P78344. | ||||||||||||||||||
Protocols and materials databases | |||||||||||||||||||
| StructuralBiologyKnowledgebase | Search... | ||||||||||||||||||
Genome annotation databases | |||||||||||||||||||
| Ensembl | ENST00000339995; ENSP00000340281; ENSG00000110321. | ||||||||||||||||||
| GeneID | 1982. | ||||||||||||||||||
| KEGG | hsa:1982. | ||||||||||||||||||
| UCSC | uc001mjb.3. human. uc001mjd.3. human. | ||||||||||||||||||
Organism-specific databases | |||||||||||||||||||
| CTD | 1982. | ||||||||||||||||||
| GeneCards | GC11M010775. | ||||||||||||||||||
| HGNC | HGNC:3297. EIF4G2. | ||||||||||||||||||
| HPA | CAB005163. HPA006773. HPA016965. | ||||||||||||||||||
| MIM | 602325. gene. | ||||||||||||||||||
| neXtProt | NX_P78344. | ||||||||||||||||||
| PharmGKB | PA27723. | ||||||||||||||||||
| GenAtlas | Search... | ||||||||||||||||||
Phylogenomic databases | |||||||||||||||||||
| eggNOG | NOG301289. | ||||||||||||||||||
| HOVERGEN | HBG052084. | ||||||||||||||||||
| InParanoid | P78344. | ||||||||||||||||||
| KO | K03260. | ||||||||||||||||||
| OrthoDB | EOG4SBDXB. | ||||||||||||||||||
Enzyme and pathway databases | |||||||||||||||||||
| Reactome | REACT_6900. Immune System. | ||||||||||||||||||
Gene expression databases | |||||||||||||||||||
| ArrayExpress | P78344. | ||||||||||||||||||
| Bgee | P78344. | ||||||||||||||||||
| CleanEx | HS_EIF4G2. | ||||||||||||||||||
| Genevestigator | P78344. | ||||||||||||||||||
| GermOnline | ENSG00000110321. Homo sapiens. | ||||||||||||||||||
Family and domain databases | |||||||||||||||||||
| Gene3D | 1.25.40.180. 3 hits. | ||||||||||||||||||
| InterPro | IPR016024. ARM-type_fold. IPR003891. Initiation_fac_eIF4g_MI. IPR016021. MIF4-like_typ_1/2/3. IPR003890. MIF4G-like_typ-3. IPR003307. W2_domain. [Graphical view] | ||||||||||||||||||
| Pfam | PF02847. MA3. 1 hit. PF02854. MIF4G. 1 hit. PF02020. W2. 1 hit. [Graphical view] | ||||||||||||||||||
| SMART | SM00515. eIF5C. 1 hit. SM00544. MA3. 1 hit. SM00543. MIF4G. 1 hit. [Graphical view] | ||||||||||||||||||
| SUPFAM | SSF48371. ARM-type_fold. 3 hits. | ||||||||||||||||||
| PROSITE | PS51366. MI. 1 hit. PS51363. W2. 1 hit. [Graphical view] | ||||||||||||||||||
| ProtoNet | Search... | ||||||||||||||||||
Other | |||||||||||||||||||
| ChiTaRS | EIF4G2. human. | ||||||||||||||||||
| EvolutionaryTrace | P78344. | ||||||||||||||||||
| GenomeRNAi | 1982. | ||||||||||||||||||
| NextBio | 8025. | ||||||||||||||||||
| PMAP-CutDB | P78344. | ||||||||||||||||||
| SOURCE | Search... | ||||||||||||||||||
Entry information
| Entry name | IF4G2_HUMAN | ||||||||
| Accession | Primary (citable) accession number: P78344 Secondary accession number(s): O60877 Q96C16 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Human chromosome 11 Human chromosome 11: entries, gene names and cross-references to MIM |
| Human entries with polymorphisms or disease mutations List of human entries with polymorphisms or disease mutations |
| Human polymorphisms and disease mutations Index of human polymorphisms and disease mutations |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| PDB cross-references Index of Protein Data Bank (PDB) cross-references |
| SIMILARITY comments Index of protein domains and families |

Clusters with
